Global Beta-Adrenoceptor Agonists Market Growth 2022-2028
Beta-adrenoceptor agonists (β-agonists) bind to the β-receptors on the smooth muscle tissues and cardiac tissues. They also have important actions in other tissues, especially bronchial smooth muscle, the liver, and kidneys. Beta-adrenoceptors usually bind to norepinephrine that is released by the sympathetic adrenergic nerves, and to circulating epinephrine. It is of great importance to the healthcare sector and thus is expected to rise high in the forecast period.
The global market for Beta-Adrenoceptor Agonists is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Beta-Adrenoceptor Agonists market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Beta-Adrenoceptor Agonists market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Beta-Adrenoceptor Agonists market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Beta-Adrenoceptor Agonists market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Beta-Adrenoceptor Agonists players cover F. Hoffmann-La Roche Ltd, Mylan NV, Teva Pharmaceutical Industries Ltd, Sanofi and Pfizer Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Beta-Adrenoceptor Agonists market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Beta-Adrenoceptor Agonists market, with both quantitative and qualitative data, to help readers understand how the Beta-Adrenoceptor Agonists market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Beta-Adrenoceptor Agonists market and forecasts the market size by Type (β 1 Agonist and β 2 Agonists,), by Application (Asthma, Anaphylactic Shock, Severe Hypotension and Acute Heart Failure), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
β 1 Agonist
β 2 Agonists
Segmentation by application
Asthma
Anaphylactic Shock
Severe Hypotension
Acute Heart Failure
Acute Renal Failure
Other
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
F. Hoffmann-La Roche Ltd
Mylan NV
Teva Pharmaceutical Industries Ltd
Sanofi
Pfizer Inc
GSK plc
Novartis AG
Bayer AG
Lilly
Merck & Co., Inc
Sun Pharmaceutical Industries Ltd
Aurobindo Pharma
Lupin
Amneal Pharmaceuticals LLC
Eisai Co., Ltd
Chapter Introduction
Chapter 1: Scope of Beta-Adrenoceptor Agonists, Research Methodology, etc.
Chapter 2: Executive Summary, global Beta-Adrenoceptor Agonists market size (sales and revenue) and CAGR, Beta-Adrenoceptor Agonists market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Beta-Adrenoceptor Agonists sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Beta-Adrenoceptor Agonists sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Beta-Adrenoceptor Agonists market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including F. Hoffmann-La Roche Ltd, Mylan NV, Teva Pharmaceutical Industries Ltd, Sanofi, Pfizer Inc, GSK plc, Novartis AG, Bayer AG and Lilly, etc.
Chapter 14: Research Findings and Conclusion
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Beta-Adrenoceptor Agonists Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Beta-Adrenoceptor Agonists by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Beta-Adrenoceptor Agonists by Country/Region, 2017, 2022 & 2028
2.2 Beta-Adrenoceptor Agonists Segment by Type
2.2.1 β 1 Agonist
2.2.2 β 2 Agonists
2.3 Beta-Adrenoceptor Agonists Sales by Type
2.3.1 Global Beta-Adrenoceptor Agonists Sales Market Share by Type (2017-2022)
2.3.2 Global Beta-Adrenoceptor Agonists Revenue and Market Share by Type (2017-2022)
2.3.3 Global Beta-Adrenoceptor Agonists Sale Price by Type (2017-2022)
2.4 Beta-Adrenoceptor Agonists Segment by Application
2.4.1 Asthma
2.4.2 Anaphylactic Shock
2.4.3 Severe Hypotension
2.4.4 Acute Heart Failure
2.4.5 Acute Renal Failure
2.4.6 Other
2.5 Beta-Adrenoceptor Agonists Sales by Application
2.5.1 Global Beta-Adrenoceptor Agonists Sale Market Share by Application (2017-2022)
2.5.2 Global Beta-Adrenoceptor Agonists Revenue and Market Share by Application (2017-2022)
2.5.3 Global Beta-Adrenoceptor Agonists Sale Price by Application (2017-2022)
3 Global Beta-Adrenoceptor Agonists by Company
3.1 Global Beta-Adrenoceptor Agonists Breakdown Data by Company
3.1.1 Global Beta-Adrenoceptor Agonists Annual Sales by Company (2020-2022)
3.1.2 Global Beta-Adrenoceptor Agonists Sales Market Share by Company (2020-2022)
3.2 Global Beta-Adrenoceptor Agonists Annual Revenue by Company (2020-2022)
3.2.1 Global Beta-Adrenoceptor Agonists Revenue by Company (2020-2022)
3.2.2 Global Beta-Adrenoceptor Agonists Revenue Market Share by Company (2020-2022)
3.3 Global Beta-Adrenoceptor Agonists Sale Price by Company
3.4 Key Manufacturers Beta-Adrenoceptor Agonists Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Beta-Adrenoceptor Agonists Product Location Distribution
3.4.2 Players Beta-Adrenoceptor Agonists Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Beta-Adrenoceptor Agonists by Geographic Region
4.1 World Historic Beta-Adrenoceptor Agonists Market Size by Geographic Region (2017-2022)
4.1.1 Global Beta-Adrenoceptor Agonists Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Beta-Adrenoceptor Agonists Annual Revenue by Geographic Region
4.2 World Historic Beta-Adrenoceptor Agonists Market Size by Country/Region (2017-2022)
4.2.1 Global Beta-Adrenoceptor Agonists Annual Sales by Country/Region (2017-2022)
4.2.2 Global Beta-Adrenoceptor Agonists Annual Revenue by Country/Region
4.3 Americas Beta-Adrenoceptor Agonists Sales Growth
4.4 APAC Beta-Adrenoceptor Agonists Sales Growth
4.5 Europe Beta-Adrenoceptor Agonists Sales Growth
4.6 Middle East & Africa Beta-Adrenoceptor Agonists Sales Growth
5 Americas
5.1 Americas Beta-Adrenoceptor Agonists Sales by Country
5.1.1 Americas Beta-Adrenoceptor Agonists Sales by Country (2017-2022)
5.1.2 Americas Beta-Adrenoceptor Agonists Revenue by Country (2017-2022)
5.2 Americas Beta-Adrenoceptor Agonists Sales by Type
5.3 Americas Beta-Adrenoceptor Agonists Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Beta-Adrenoceptor Agonists Sales by Region
6.1.1 APAC Beta-Adrenoceptor Agonists Sales by Region (2017-2022)
6.1.2 APAC Beta-Adrenoceptor Agonists Revenue by Region (2017-2022)
6.2 APAC Beta-Adrenoceptor Agonists Sales by Type
6.3 APAC Beta-Adrenoceptor Agonists Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Beta-Adrenoceptor Agonists by Country
7.1.1 Europe Beta-Adrenoceptor Agonists Sales by Country (2017-2022)
7.1.2 Europe Beta-Adrenoceptor Agonists Revenue by Country (2017-2022)
7.2 Europe Beta-Adrenoceptor Agonists Sales by Type
7.3 Europe Beta-Adrenoceptor Agonists Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Beta-Adrenoceptor Agonists by Country
8.1.1 Middle East & Africa Beta-Adrenoceptor Agonists Sales by Country (2017-2022)
8.1.2 Middle East & Africa Beta-Adrenoceptor Agonists Revenue by Country (2017-2022)
8.2 Middle East & Africa Beta-Adrenoceptor Agonists Sales by Type
8.3 Middle East & Africa Beta-Adrenoceptor Agonists Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Beta-Adrenoceptor Agonists
10.3 Manufacturing Process Analysis of Beta-Adrenoceptor Agonists
10.4 Industry Chain Structure of Beta-Adrenoceptor Agonists
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Beta-Adrenoceptor Agonists Distributors
11.3 Beta-Adrenoceptor Agonists Customer
12 World Forecast Review for Beta-Adrenoceptor Agonists by Geographic Region
12.1 Global Beta-Adrenoceptor Agonists Market Size Forecast by Region
12.1.1 Global Beta-Adrenoceptor Agonists Forecast by Region (2023-2028)
12.1.2 Global Beta-Adrenoceptor Agonists Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Beta-Adrenoceptor Agonists Forecast by Type
12.7 Global Beta-Adrenoceptor Agonists Forecast by Application
13 Key Players Analysis
13.1 F. Hoffmann-La Roche Ltd
13.1.1 F. Hoffmann-La Roche Ltd Company Information
13.1.2 F. Hoffmann-La Roche Ltd Beta-Adrenoceptor Agonists Product Offered
13.1.3 F. Hoffmann-La Roche Ltd Beta-Adrenoceptor Agonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 F. Hoffmann-La Roche Ltd Main Business Overview
13.1.5 F. Hoffmann-La Roche Ltd Latest Developments
13.2 Mylan NV
13.2.1 Mylan NV Company Information
13.2.2 Mylan NV Beta-Adrenoceptor Agonists Product Offered
13.2.3 Mylan NV Beta-Adrenoceptor Agonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Mylan NV Main Business Overview
13.2.5 Mylan NV Latest Developments
13.3 Teva Pharmaceutical Industries Ltd
13.3.1 Teva Pharmaceutical Industries Ltd Company Information
13.3.2 Teva Pharmaceutical Industries Ltd Beta-Adrenoceptor Agonists Product Offered
13.3.3 Teva Pharmaceutical Industries Ltd Beta-Adrenoceptor Agonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.3.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.4 Sanofi
13.4.1 Sanofi Company Information
13.4.2 Sanofi Beta-Adrenoceptor Agonists Product Offered
13.4.3 Sanofi Beta-Adrenoceptor Agonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sanofi Main Business Overview
13.4.5 Sanofi Latest Developments
13.5 Pfizer Inc
13.5.1 Pfizer Inc Company Information
13.5.2 Pfizer Inc Beta-Adrenoceptor Agonists Product Offered
13.5.3 Pfizer Inc Beta-Adrenoceptor Agonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Pfizer Inc Main Business Overview
13.5.5 Pfizer Inc Latest Developments
13.6 GSK plc
13.6.1 GSK plc Company Information
13.6.2 GSK plc Beta-Adrenoceptor Agonists Product Offered
13.6.3 GSK plc Beta-Adrenoceptor Agonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 GSK plc Main Business Overview
13.6.5 GSK plc Latest Developments
13.7 Novartis AG
13.7.1 Novartis AG Company Information
13.7.2 Novartis AG Beta-Adrenoceptor Agonists Product Offered
13.7.3 Novartis AG Beta-Adrenoceptor Agonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Novartis AG Main Business Overview
13.7.5 Novartis AG Latest Developments
13.8 Bayer AG
13.8.1 Bayer AG Company Information
13.8.2 Bayer AG Beta-Adrenoceptor Agonists Product Offered
13.8.3 Bayer AG Beta-Adrenoceptor Agonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bayer AG Main Business Overview
13.8.5 Bayer AG Latest Developments
13.9 Lilly
13.9.1 Lilly Company Information
13.9.2 Lilly Beta-Adrenoceptor Agonists Product Offered
13.9.3 Lilly Beta-Adrenoceptor Agonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Lilly Main Business Overview
13.9.5 Lilly Latest Developments
13.10 Merck & Co., Inc
13.10.1 Merck & Co., Inc Company Information
13.10.2 Merck & Co., Inc Beta-Adrenoceptor Agonists Product Offered
13.10.3 Merck & Co., Inc Beta-Adrenoceptor Agonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Merck & Co., Inc Main Business Overview
13.10.5 Merck & Co., Inc Latest Developments
13.11 Sun Pharmaceutical Industries Ltd
13.11.1 Sun Pharmaceutical Industries Ltd Company Information
13.11.2 Sun Pharmaceutical Industries Ltd Beta-Adrenoceptor Agonists Product Offered
13.11.3 Sun Pharmaceutical Industries Ltd Beta-Adrenoceptor Agonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Sun Pharmaceutical Industries Ltd Main Business Overview
13.11.5 Sun Pharmaceutical Industries Ltd Latest Developments
13.12 Aurobindo Pharma
13.12.1 Aurobindo Pharma Company Information
13.12.2 Aurobindo Pharma Beta-Adrenoceptor Agonists Product Offered
13.12.3 Aurobindo Pharma Beta-Adrenoceptor Agonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Aurobindo Pharma Main Business Overview
13.12.5 Aurobindo Pharma Latest Developments
13.13 Lupin
13.13.1 Lupin Company Information
13.13.2 Lupin Beta-Adrenoceptor Agonists Product Offered
13.13.3 Lupin Beta-Adrenoceptor Agonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Lupin Main Business Overview
13.13.5 Lupin Latest Developments
13.14 Amneal Pharmaceuticals LLC
13.14.1 Amneal Pharmaceuticals LLC Company Information
13.14.2 Amneal Pharmaceuticals LLC Beta-Adrenoceptor Agonists Product Offered
13.14.3 Amneal Pharmaceuticals LLC Beta-Adrenoceptor Agonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Amneal Pharmaceuticals LLC Main Business Overview
13.14.5 Amneal Pharmaceuticals LLC Latest Developments
13.15 Eisai Co., Ltd
13.15.1 Eisai Co., Ltd Company Information
13.15.2 Eisai Co., Ltd Beta-Adrenoceptor Agonists Product Offered
13.15.3 Eisai Co., Ltd Beta-Adrenoceptor Agonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Eisai Co., Ltd Main Business Overview
13.15.5 Eisai Co., Ltd Latest Developments
14 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Beta-Adrenoceptor Agonists Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Beta-Adrenoceptor Agonists Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of β 1 Agonist
Table 4. Major Players of β 2 Agonists
Table 5. Global Beta-Adrenoceptor Agonists Sales by Type (2017-2022) & (K Units)
Table 6. Global Beta-Adrenoceptor Agonists Sales Market Share by Type (2017-2022)
Table 7. Global Beta-Adrenoceptor Agonists Revenue by Type (2017-2022) & ($ million)
Table 8. Global Beta-Adrenoceptor Agonists Revenue Market Share by Type (2017-2022)
Table 9. Global Beta-Adrenoceptor Agonists Sale Price by Type (2017-2022) & (US$/Unit)
Table 10. Global Beta-Adrenoceptor Agonists Sales by Application (2017-2022) & (K Units)
Table 11. Global Beta-Adrenoceptor Agonists Sales Market Share by Application (2017-2022)
Table 12. Global Beta-Adrenoceptor Agonists Revenue by Application (2017-2022)
Table 13. Global Beta-Adrenoceptor Agonists Revenue Market Share by Application (2017-2022)
Table 14. Global Beta-Adrenoceptor Agonists Sale Price by Application (2017-2022) & (US$/Unit)
Table 15. Global Beta-Adrenoceptor Agonists Sales by Company (2020-2022) & (K Units)
Table 16. Global Beta-Adrenoceptor Agonists Sales Market Share by Company (2020-2022)
Table 17. Global Beta-Adrenoceptor Agonists Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Beta-Adrenoceptor Agonists Revenue Market Share by Company (2020-2022)
Table 19. Global Beta-Adrenoceptor Agonists Sale Price by Company (2020-2022) & (US$/Unit)
Table 20. Key Manufacturers Beta-Adrenoceptor Agonists Producing Area Distribution and Sales Area
Table 21. Players Beta-Adrenoceptor Agonists Products Offered
Table 22. Beta-Adrenoceptor Agonists Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Beta-Adrenoceptor Agonists Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global Beta-Adrenoceptor Agonists Sales Market Share Geographic Region (2017-2022)
Table 27. Global Beta-Adrenoceptor Agonists Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Beta-Adrenoceptor Agonists Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Beta-Adrenoceptor Agonists Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global Beta-Adrenoceptor Agonists Sales Market Share by Country/Region (2017-2022)
Table 31. Global Beta-Adrenoceptor Agonists Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Beta-Adrenoceptor Agonists Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Beta-Adrenoceptor Agonists Sales by Country (2017-2022) & (K Units)
Table 34. Americas Beta-Adrenoceptor Agonists Sales Market Share by Country (2017-2022)
Table 35. Americas Beta-Adrenoceptor Agonists Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Beta-Adrenoceptor Agonists Revenue Market Share by Country (2017-2022)
Table 37. Americas Beta-Adrenoceptor Agonists Sales by Type (2017-2022) & (K Units)
Table 38. Americas Beta-Adrenoceptor Agonists Sales Market Share by Type (2017-2022)
Table 39. Americas Beta-Adrenoceptor Agonists Sales by Application (2017-2022) & (K Units)
Table 40. Americas Beta-Adrenoceptor Agonists Sales Market Share by Application (2017-2022)
Table 41. APAC Beta-Adrenoceptor Agonists Sales by Region (2017-2022) & (K Units)
Table 42. APAC Beta-Adrenoceptor Agonists Sales Market Share by Region (2017-2022)
Table 43. APAC Beta-Adrenoceptor Agonists Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Beta-Adrenoceptor Agonists Revenue Market Share by Region (2017-2022)
Table 45. APAC Beta-Adrenoceptor Agonists Sales by Type (2017-2022) & (K Units)
Table 46. APAC Beta-Adrenoceptor Agonists Sales Market Share by Type (2017-2022)
Table 47. APAC Beta-Adrenoceptor Agonists Sales by Application (2017-2022) & (K Units)
Table 48. APAC Beta-Adrenoceptor Agonists Sales Market Share by Application (2017-2022)
Table 49. Europe Beta-Adrenoceptor Agonists Sales by Country (2017-2022) & (K Units)
Table 50. Europe Beta-Adrenoceptor Agonists Sales Market Share by Country (2017-2022)
Table 51. Europe Beta-Adrenoceptor Agonists Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Beta-Adrenoceptor Agonists Revenue Market Share by Country (2017-2022)
Table 53. Europe Beta-Adrenoceptor Agonists Sales by Type (2017-2022) & (K Units)
Table 54. Europe Beta-Adrenoceptor Agonists Sales Market Share by Type (2017-2022)
Table 55. Europe Beta-Adrenoceptor Agonists Sales by Application (2017-2022) & (K Units)
Table 56. Europe Beta-Adrenoceptor Agonists Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Beta-Adrenoceptor Agonists Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa Beta-Adrenoceptor Agonists Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Beta-Adrenoceptor Agonists Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Beta-Adrenoceptor Agonists Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Beta-Adrenoceptor Agonists Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa Beta-Adrenoceptor Agonists Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Beta-Adrenoceptor Agonists Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa Beta-Adrenoceptor Agonists Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Beta-Adrenoceptor Agonists
Table 66. Key Market Challenges & Risks of Beta-Adrenoceptor Agonists
Table 67. Key Industry Trends of Beta-Adrenoceptor Agonists
Table 68. Beta-Adrenoceptor Agonists Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Beta-Adrenoceptor Agonists Distributors List
Table 71. Beta-Adrenoceptor Agonists Customer List
Table 72. Global Beta-Adrenoceptor Agonists Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global Beta-Adrenoceptor Agonists Sales Market Forecast by Region
Table 74. Global Beta-Adrenoceptor Agonists Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Beta-Adrenoceptor Agonists Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Beta-Adrenoceptor Agonists Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas Beta-Adrenoceptor Agonists Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Beta-Adrenoceptor Agonists Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC Beta-Adrenoceptor Agonists Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Beta-Adrenoceptor Agonists Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe Beta-Adrenoceptor Agonists Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Beta-Adrenoceptor Agonists Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa Beta-Adrenoceptor Agonists Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Beta-Adrenoceptor Agonists Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global Beta-Adrenoceptor Agonists Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Beta-Adrenoceptor Agonists Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Beta-Adrenoceptor Agonists Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Beta-Adrenoceptor Agonists Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global Beta-Adrenoceptor Agonists Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Beta-Adrenoceptor Agonists Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Beta-Adrenoceptor Agonists Revenue Market Share Forecast by Application (2023-2028)
Table 92. F. Hoffmann-La Roche Ltd Basic Information, Beta-Adrenoceptor Agonists Manufacturing Base, Sales Area and Its Competitors
Table 93. F. Hoffmann-La Roche Ltd Beta-Adrenoceptor Agonists Product Offered
Table 94. F. Hoffmann-La Roche Ltd Beta-Adrenoceptor Agonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 95. F. Hoffmann-La Roche Ltd Main Business
Table 96. F. Hoffmann-La Roche Ltd Latest Developments
Table 97. Mylan NV Basic Information, Beta-Adrenoceptor Agonists Manufacturing Base, Sales Area and Its Competitors
Table 98. Mylan NV Beta-Adrenoceptor Agonists Product Offered
Table 99. Mylan NV Beta-Adrenoceptor Agonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 100. Mylan NV Main Business
Table 101. Mylan NV Latest Developments
Table 102. Teva Pharmaceutical Industries Ltd Basic Information, Beta-Adrenoceptor Agonists Manufacturing Base, Sales Area and Its Competitors
Table 103. Teva Pharmaceutical Industries Ltd Beta-Adrenoceptor Agonists Product Offered
Table 104. Teva Pharmaceutical Industries Ltd Beta-Adrenoceptor Agonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 105. Teva Pharmaceutical Industries Ltd Main Business
Table 106. Teva Pharmaceutical Industries Ltd Latest Developments
Table 107. Sanofi Basic Information, Beta-Adrenoceptor Agonists Manufacturing Base, Sales Area and Its Competitors
Table 108. Sanofi Beta-Adrenoceptor Agonists Product Offered
Table 109. Sanofi Beta-Adrenoceptor Agonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 110. Sanofi Main Business
Table 111. Sanofi Latest Developments
Table 112. Pfizer Inc Basic Information, Beta-Adrenoceptor Agonists Manufacturing Base, Sales Area and Its Competitors
Table 113. Pfizer Inc Beta-Adrenoceptor Agonists Product Offered
Table 114. Pfizer Inc Beta-Adrenoceptor Agonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 115. Pfizer Inc Main Business
Table 116. Pfizer Inc Latest Developments
Table 117. GSK plc Basic Information, Beta-Adrenoceptor Agonists Manufacturing Base, Sales Area and Its Competitors
Table 118. GSK plc Beta-Adrenoceptor Agonists Product Offered
Table 119. GSK plc Beta-Adrenoceptor Agonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 120. GSK plc Main Business
Table 121. GSK plc Latest Developments
Table 122. Novartis AG Basic Information, Beta-Adrenoceptor Agonists Manufacturing Base, Sales Area and Its Competitors
Table 123. Novartis AG Beta-Adrenoceptor Agonists Product Offered
Table 124. Novartis AG Beta-Adrenoceptor Agonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 125. Novartis AG Main Business
Table 126. Novartis AG Latest Developments
Table 127. Bayer AG Basic Information, Beta-Adrenoceptor Agonists Manufacturing Base, Sales Area and Its Competitors
Table 128. Bayer AG Beta-Adrenoceptor Agonists Product Offered
Table 129. Bayer AG Beta-Adrenoceptor Agonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 130. Bayer AG Main Business
Table 131. Bayer AG Latest Developments
Table 132. Lilly Basic Information, Beta-Adrenoceptor Agonists Manufacturing Base, Sales Area and Its Competitors
Table 133. Lilly Beta-Adrenoceptor Agonists Product Offered
Table 134. Lilly Beta-Adrenoceptor Agonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 135. Lilly Main Business
Table 136. Lilly Latest Developments
Table 137. Merck & Co., Inc Basic Information, Beta-Adrenoceptor Agonists Manufacturing Base, Sales Area and Its Competitors
Table 138. Merck & Co., Inc Beta-Adrenoceptor Agonists Product Offered
Table 139. Merck & Co., Inc Beta-Adrenoceptor Agonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 140. Merck & Co., Inc Main Business
Table 141. Merck & Co., Inc Latest Developments
Table 142. Sun Pharmaceutical Industries Ltd Basic Information, Beta-Adrenoceptor Agonists Manufacturing Base, Sales Area and Its Competitors
Table 143. Sun Pharmaceutical Industries Ltd Beta-Adrenoceptor Agonists Product Offered
Table 144. Sun Pharmaceutical Industries Ltd Beta-Adrenoceptor Agonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 145. Sun Pharmaceutical Industries Ltd Main Business
Table 146. Sun Pharmaceutical Industries Ltd Latest Developments
Table 147. Aurobindo Pharma Basic Information, Beta-Adrenoceptor Agonists Manufacturing Base, Sales Area and Its Competitors
Table 148. Aurobindo Pharma Beta-Adrenoceptor Agonists Product Offered
Table 149. Aurobindo Pharma Beta-Adrenoceptor Agonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 150. Aurobindo Pharma Main Business
Table 151. Aurobindo Pharma Latest Developments
Table 152. Lupin Basic Information, Beta-Adrenoceptor Agonists Manufacturing Base, Sales Area and Its Competitors
Table 153. Lupin Beta-Adrenoceptor Agonists Product Offered
Table 154. Lupin Beta-Adrenoceptor Agonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 155. Lupin Main Business
Table 156. Lupin Latest Developments
Table 157. Amneal Pharmaceuticals LLC Basic Information, Beta-Adrenoceptor Agonists Manufacturing Base, Sales Area and Its Competitors
Table 158. Amneal Pharmaceuticals LLC Beta-Adrenoceptor Agonists Product Offered
Table 159. Amneal Pharmaceuticals LLC Beta-Adrenoceptor Agonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 160. Amneal Pharmaceuticals LLC Main Business
Table 161. Amneal Pharmaceuticals LLC Latest Developments
Table 162. Eisai Co., Ltd Basic Information, Beta-Adrenoceptor Agonists Manufacturing Base, Sales Area and Its Competitors
Table 163. Eisai Co., Ltd Beta-Adrenoceptor Agonists Product Offered
Table 164. Eisai Co., Ltd Beta-Adrenoceptor Agonists Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 165. Eisai Co., Ltd Main Business
Table 166. Eisai Co., Ltd Latest Developments
List of Figures
Figure 1. Picture of Beta-Adrenoceptor Agonists
Figure 2. Beta-Adrenoceptor Agonists Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Beta-Adrenoceptor Agonists Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Beta-Adrenoceptor Agonists Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Beta-Adrenoceptor Agonists Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of β 1 Agonist
Figure 10. Product Picture of β 2 Agonists
Figure 11. Global Beta-Adrenoceptor Agonists Sales Market Share by Type in 2021
Figure 12. Global Beta-Adrenoceptor Agonists Revenue Market Share by Type (2017-2022)
Figure 13. Beta-Adrenoceptor Agonists Consumed in Asthma
Figure 14. Global Beta-Adrenoceptor Agonists Market: Asthma (2017-2022) & (K Units)
Figure 15. Beta-Adrenoceptor Agonists Consumed in Anaphylactic Shock
Figure 16. Global Beta-Adrenoceptor Agonists Market: Anaphylactic Shock (2017-2022) & (K Units)
Figure 17. Beta-Adrenoceptor Agonists Consumed in Severe Hypotension
Figure 18. Global Beta-Adrenoceptor Agonists Market: Severe Hypotension (2017-2022) & (K Units)
Figure 19. Beta-Adrenoceptor Agonists Consumed in Acute Heart Failure
Figure 20. Global Beta-Adrenoceptor Agonists Market: Acute Heart Failure (2017-2022) & (K Units)
Figure 21. Beta-Adrenoceptor Agonists Consumed in Acute Renal Failure
Figure 22. Global Beta-Adrenoceptor Agonists Market: Acute Renal Failure (2017-2022) & (K Units)
Figure 23. Beta-Adrenoceptor Agonists Consumed in Other
Figure 24. Global Beta-Adrenoceptor Agonists Market: Other (2017-2022) & (K Units)
Figure 25. Global Beta-Adrenoceptor Agonists Sales Market Share by Application (2017-2022)
Figure 26. Global Beta-Adrenoceptor Agonists Revenue Market Share by Application in 2021
Figure 27. Beta-Adrenoceptor Agonists Revenue Market by Company in 2021 ($ Million)
Figure 28. Global Beta-Adrenoceptor Agonists Revenue Market Share by Company in 2021
Figure 29. Global Beta-Adrenoceptor Agonists Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global Beta-Adrenoceptor Agonists Revenue Market Share by Geographic Region in 2021
Figure 31. Global Beta-Adrenoceptor Agonists Sales Market Share by Region (2017-2022)
Figure 32. Global Beta-Adrenoceptor Agonists Revenue Market Share by Country/Region in 2021
Figure 33. Americas Beta-Adrenoceptor Agonists Sales 2017-2022 (K Units)
Figure 34. Americas Beta-Adrenoceptor Agonists Revenue 2017-2022 ($ Millions)
Figure 35. APAC Beta-Adrenoceptor Agonists Sales 2017-2022 (K Units)
Figure 36. APAC Beta-Adrenoceptor Agonists Revenue 2017-2022 ($ Millions)
Figure 37. Europe Beta-Adrenoceptor Agonists Sales 2017-2022 (K Units)
Figure 38. Europe Beta-Adrenoceptor Agonists Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa Beta-Adrenoceptor Agonists Sales 2017-2022 (K Units)
Figure 40. Middle East & Africa Beta-Adrenoceptor Agonists Revenue 2017-2022 ($ Millions)
Figure 41. Americas Beta-Adrenoceptor Agonists Sales Market Share by Country in 2021
Figure 42. Americas Beta-Adrenoceptor Agonists Revenue Market Share by Country in 2021
Figure 43. United States Beta-Adrenoceptor Agonists Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada Beta-Adrenoceptor Agonists Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico Beta-Adrenoceptor Agonists Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil Beta-Adrenoceptor Agonists Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC Beta-Adrenoceptor Agonists Sales Market Share by Region in 2021
Figure 48. APAC Beta-Adrenoceptor Agonists Revenue Market Share by Regions in 2021
Figure 49. China Beta-Adrenoceptor Agonists Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan Beta-Adrenoceptor Agonists Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea Beta-Adrenoceptor Agonists Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia Beta-Adrenoceptor Agonists Revenue Growth 2017-2022 ($ Millions)
Figure 53. India Beta-Adrenoceptor Agonists Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia Beta-Adrenoceptor Agonists Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe Beta-Adrenoceptor Agonists Sales Market Share by Country in 2021
Figure 56. Europe Beta-Adrenoceptor Agonists Revenue Market Share by Country in 2021
Figure 57. Germany Beta-Adrenoceptor Agonists Revenue Growth 2017-2022 ($ Millions)
Figure 58. France Beta-Adrenoceptor Agonists Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK Beta-Adrenoceptor Agonists Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy Beta-Adrenoceptor Agonists Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia Beta-Adrenoceptor Agonists Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa Beta-Adrenoceptor Agonists Sales Market Share by Country in 2021
Figure 63. Middle East & Africa Beta-Adrenoceptor Agonists Revenue Market Share by Country in 2021
Figure 64. Egypt Beta-Adrenoceptor Agonists Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa Beta-Adrenoceptor Agonists Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel Beta-Adrenoceptor Agonists Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey Beta-Adrenoceptor Agonists Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country Beta-Adrenoceptor Agonists Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of Beta-Adrenoceptor Agonists in 2021
Figure 70. Manufacturing Process Analysis of Beta-Adrenoceptor Agonists
Figure 71. Industry Chain Structure of Beta-Adrenoceptor Agonists
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets